Growth factors in the therapy of myelodisplasia: Biological aspects

Leukemia and Lymphoma

Volumn 26, Issue SUPPL. 1, 1997, Pages 35-40

  Bonfichi, Maurizio ^a   Astori, Cesare ^a   Alessandrino, Emilio Paolo ^a   Balduini, Paolo Bernasconi Alessandra ^a   Castagnola, Carlo ^a   Brusamolino, Ercole ^a   Pagnucco, Guido ^a   Canevari, Angelo ^a   Trucco, Paola ^a   Bernasconi, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Growth factors; Myelodisplastic syndromes

Indexed keywords

CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; IDARUBICIN;

ACUTE LEUKEMIA; ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 7144235828     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709058598     Document Type: Conference Paper

References (18)

1. Hoelzer, D., Ganser, A. and Heimpel, H. (1984). "Atypical" leukemias: Preleukemia, smouldering leukemia and hypoplastic leukemia: Recent results. Cancer. Res., 93, 69-101.
2. Geissler, K., Hinterberger, W. and Bettelheim, P. (1988). Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res, 12, 373-377.
3. Bonfichi, M., Bernasconi, P., Alessandrino, E. P., Brunetti, A., Boni, M., Brera, C., Castelli, G., Lazzarino, M. and Bernasconi, C. (1991). Prognostic significance of hone marrow CFU-GM and cytogenetic studies in primary myelodisplastic syndromes (MDS). Leuk. Res., 15, 29.
4. Nagler, A., Binet, C., Mac Kichan, M. L., Negrin, R., Bangs, D., Donlon, T. and Greenberg, P. (1990). Impact of marrow cyto-genetics and morphology on in vitro hematopoiesis in the myelodisplastic syndromes: comparison between recombinant human granulocyte granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF. Blood, 76(7), 1299-1307.
5. Nagler, A., Ginzton, N., Negrin, R., Bangs, D., Donlon, T. and Greenberg. P. (1990). Effects of recombinant human granulocyte colony stimulating factor on in vitro hemopoiesis in the myelodisplastic syndromes. Leukemia, 4. 193-202.
6. Nagler, A., MacKichan, M. L., Negrin, R., Donlon, T. and Greenberg, P. L. (1995). Effects of granulocyte colony-stimulating factor on in vitro hemopoiesis in the myelodisplastic syndromes. Leukemia, 9, 30-39.
7. Greenberg, P. L., Negrin, R. and Ginzton, N. (1991). G-CSF synergizes with erythropoietin (EPO) for enhancing erythroid colony-formation (BFU-E) in myelodisplastic syndromes (MDS). Blood, 78 (suppl), 38a.
8. Nagler, A., Ginzton, N., Negrin, R. S., Donlon, T., Souza, L. and Greenberg, P. L. (1988). In vitro effects of recombinant human granulocyte (G-CSF) and granulocyte-monocyte (GM-CSF) colony stimulating factors on hematopoiesys in the myelodysplastic syndromes. Blood, 72, 128.
9. Mayani, H., Baines, P., Bowen, D. T. and Jacobs, A. (1989). In vitro growth of myeloid and erythroid progenitor cells from mylodisplastic patients in response to recombinant human granulocyte-macrophage colony stimulating factor. Leukemia, 3, 29-32.
10. Pierelli, L., Menichella, G., Scambia, G., Teofili L., Iovino, S., Serafini, R., Benedetti Panici, P., Salerno, G., Rumi, C., Zini, G., d'Onofrio, G., Leone, G., Mancuso, S., Bizzi, B. (1994). In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells. Bone Marrow Transplant, 14, 23-30.
11. Soligo, D. A., Campiglio, S., Servue, F., Bossolasco, P., Romiti, L., Cortellezzi, A., Lambertenghi-Deliliers, G. (1996). Response of myelodisplastic syndrome marrow progenitor cells to stimulation with cytokine combinations in a stroma-free long-term culture system. Br. J. Haematol, 92, 548-551.
12. Backx, B., Broeders, L. and Lowenberg, B. (1992). Kit-ligand improves erythropoiesys in myelodisplastic syndrome. Blood, 80, 1213-1217.
13. Piacibello, W., Sanavio, F., Bresso, P., Severino, A., Carlesso, N., Pregno, P., Stacchini, A., Morelli, S., Fubini, L., Gallo, E., Aglietta, M. and Ferrero, D. (1994). Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodisplastic syndromes. Leukemia, 8, 250-257.
14. Glinsmann-Gibson, B., Spier, C., Baier, M., Taetle, R., Broudy, V. C. and List, A. F. (1994). Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodisplastic syndrome. Leukemia, 5, 827-832.
15. Delwel, R., Dorssers, L., Touw, I., Wagemaker, G., Lowenberg, B. (1987). Human recombinant multi-lineage coony stimulating factor (interleukin 3) : stimulator of acute myeloblastic leukemia progenitor cells in vitro. Blood, 70(1), 333-336.
16. Verhoef, G. E. G. and Boogaerts, M. A. (1996). Cytogenetics and its prognostic value in myelodisplastic syndromes. Acta Haematol, 95, 95-101.
17. Ikeda, H., Kanakura, Y., Tamaki, T., Curiu, A., Kitayama, H., Ishikawa, J., Kamayama, J., Yonezawa, T., Tarui, S. and Griffin, J. D. (1991). EXpression and functional role of the proto-oncogene c-kit in acute myeloblastic cells. Blood, 78, 2962-2968.
18. Bernasconi, C., Alessandrino, E. P., Bernasconi, P., Bonfichi, M., Caldera, D., Lazzarino, M., Canevari, A., Brusamolino, E., Pagnucco, G. and Castagnola, C. (1996). Intensive chemotherapy combined with G-CSF and allogeneic Bone Marrow Transplantation (BMT) in high risk myelodisplastic syndromes (MDS) or acute leukemia (AL) evolving from MDS. Br J Haematol, 93(2), 157.